Global Biologics Market is Estimated to Witness High Growth Owing to Increasing R&D Investments and Rising Demand for Personalized Medicine


Biologics Market



The global Biologics Market is estimated to be valued at US$ 401.96 billion in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030.

 A) Market Overview:

The biologics market comprises a diverse range of products including monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. These products are derived from living organisms or contain components of living organisms. Biologics have revolutionized the treatment of various diseases by offering targeted therapies with fewer side effects. They are widely used in the treatment of cancer, autoimmune disorders, and infectious diseases. For instance, monoclonal antibodies such as rituximab and trastuzumab have greatly improved survival rates in patients with cancer.

 B) Market Dynamics:

The biologics market is driven by two major factors: increasing investments in research and development and the rising demand for personalized medicine.

 1. Increasing R&D Investments: Pharmaceutical companies are heavily investing in the development of biologics due to their high efficacy and specificity. The advancements in biotechnology and genetic engineering techniques have enabled the discovery and production of novel biologic drugs. For example, Novartis AG invested over US$ 10 billion in R&D activities in 2020 to develop innovative biologic therapies.

2. Rising Demand for Personalized Medicine: Biologics Market play a crucial role in personalized medicine as they can be designed to target specific molecular targets or genetic mutations. This enables healthcare providers to tailor treatments according to individual patient characteristics, resulting in better treatment outcomes. AstraZeneca PLC's Tagrisso, a targeted therapy for non-small cell lung cancer (NSCLC), is a prime example of personalized medicine.

C) Market Key Trends:

One key trend in the biologics market is the increasing adoption of biosimilars. Biosimilars are highly similar versions of already approved biologic drugs, offering therapeutic alternatives at a lower cost. The introduction of biosimilars has the potential to increase patient access to life-saving biologic therapies and reduce healthcare expenditure. For instance, Pfizer Inc. launched its biosimilar product, Trazimera, which is a biosimilar of Herceptin (trastuzumab), in the U.S. market.

D) SWOT Analysis:

- Strengths: Growing R&D investments and technological advancements.

- Weaknesses: High production costs and regulatory challenges.

- Opportunities: Increasing demand for biologic therapies in emerging markets and the development of novel biologics.

- Threats: Patent expirations and the emergence of counterfeit biologic drugs.

 

E) Key Takeaways:

In summary, the global biologics market is expected to witness high growth, exhibiting a CAGR of 9.3% over the forecast period. This growth can be attributed to increasing R&D investments and the rising demand for personalized medicine. The market size is projected to reach US$ 401.96 billion in 2023. Regionally, North America dominates the market due to its well-established healthcare infrastructure and early adoption of biologics. Key players operating in the global biologics market include Novartis AG, AstraZeneca PLC, Bayer AG, Sanofi SA, Pfizer Inc., Merck & Co., Johnson and Johnson, GlaxoSmithKline PLC, Amgen Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, and AGC Biologics. These companies are investing in research and development activities to develop innovative biologic therapies and gain a competitive edge in the market.

 

 

 

 

 


Comments

Post a Comment

Popular posts from this blog

Transfection Reagents And Equipment Market : Share,Size, Growth Opportunities During The Forecast Period From 2023-2030

Image
  Transfection Reagents And Equipment Market Nucleic acids are introduced into eukaryotic cells through transfection using non-viral techniques. The substances and tools utilized in this process are referred to as transfection substances and tools. The Transfection Reagents And Equipment Market   had a value of US$ 1,066.5 million in 2022 and is anticipated to grow at a CAGR of 9.3% from 2023 to 2030 to reach US$ 2,171.7 million. The Transfection Reagents and Equipment Market is a rapidly growing sector in the field of biotechnology, offering exciting opportunities for researchers and businesses alike. Transfection, the process of introducing foreign genetic material into cells, plays a crucial role in genetic research, gene therapy, and the development of biopharmaceuticals. The market's remarkable share, size, and growth prospects make it a focal point of interest for investors and stakeholders. Market Growth Numerous growth opportunities are emerging within the ma...
Read more

Bioethanol Market: Share, Trend, Segmentation And Forecast For The Period 2022-2028

Image
  Bioethanol Market Bioethanol, also known as ethanol, is a renewable fuel produced from organic materials such as crops, agricultural residues, and even waste materials. The Bioethanol Market refers to the global trade and production of bioethanol. It has experienced significant growth in recent years due to increasing concerns about climate change, the desire to reduce dependence on fossil fuels, and government policies promoting renewable energy sources. Market Trends : Some notable trends in the bioethanol market include a shift towards second-generation bioethanol production, which utilizes non-edible biomass and waste materials. This trend is driven by the need for sustainability and to avoid competition with food crops. Additionally, advancements in technology and research have focused on improving the efficiency and cost-effectiveness of bioethanol production processes. Market Segmentation : The Bioethanol Market can be segmented based on feedstock type, applicati...
Read more

Global Ride-Hailing Market Poised For Rapid Growth Driven By Technological Advancements And Changing Consumer Preferences

Image
  Ride-Hailing Market A) Market Overview: The global Ride-Hailing Market is estimated to be valued at US$151,600.0 million in 2021 and is expected to reach new heights, reaching a market value of US$BN/Mn by 2022. This growth is projected to be driven by increasing smartphone penetration, rising urbanization, and shifting consumer preferences towards convenient and cost-effective transportation options. Ride-hailing services provide users with a convenient alternative to traditional modes of transportation, offering personalized transportation on-demand through mobile applications. With the proliferation of ride-hailing platforms, consumers now have access to various transport options, including cars, bikes, and e-scooters, enhancing the overall mobility experience. B) Market Dynamics : 1. Technological Advancements: The ride-hailing market is benefitting from advancements in technology, including the integration of artificial intelligence and machine learning algorithms. These...
Read more